Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1944
result was found. Results that relate to
R
Comparision of plasma concentrations of different load regimes of teicoplanin in patients with osteomyelitis by liquid chromatography-mass spectrometry monitoring
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):51-58.
5269 times
1239 times
Hui-Min YU
Hui-Jie YUE
Hong-Bo QIAN
Yan-Jie ZHANG
Zhi-Wei HE
Qing ZHOU
Teicoplanin
Loading
r
egimen
T
r
ough concent
r
ation
The
r
apeutic d
r
ug monito
r
ing
LC-MS/MS
Details
Prediction of aripiprazole blood concentration by GA-BP artificial neural network
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):59-66.
5807 times
1205 times
Ze-Ping YANG
Ting ZHAO
Ting-Ting WANG
Jie FENG
Hui-Lan ZHANG
Li SUN
Hong-Jian LI
Lu-Hai YU
Genetic algo
r
ithm back p
r
opagation
A
r
tificial neu
r
al netwo
r
k
A
r
ipip
r
azole
Dehyd
r
oa
r
ipip
r
azole
P
r
ediction of blood d
r
ug concent
r
ation
Details
Monitoring of trough concentration of mycophenolic acid in plasma of patients with systemic lupus erthematosus by LC-MS/MS
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):67-73.
5685 times
1155 times
Xi-Ping LI
Heng-Yi YU
Dong XIANG
Dong LIU
Xue-Peng GONG
Mycophenolic acid
LC-MS/MS
The
r
apeutic d
r
ug monito
r
ing
Systemic lupus e
r
ythematosus
Details
Establishment of anti CD80 drug binding activity method based on SPR technology
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):74-81.
5960 times
1116 times
Shan-Shan DONG
Zhuo-Wei SHI
Xu-Hua DUAN
Hong SHAO
Gang CHEN
Su
r
face plasmon
r
esonance
Anti-CD80 biomedicines
Binding activity
CM5 chip
Details
Screening the formulation and process of paclitaxel injection by full factorial experimental design and its characterization
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):82-89.
5407 times
1141 times
Deng-Shan ZHANG
Liu-Cheng LIU
Paclitaxel injection
Fo
r
mulation and p
r
ocess optimization
Full facto
r
ial expe
r
imental design
Pa
r
ticle size dist
r
ibution
Zeta potential
Details
Effects of different doses of rosuvastatin on ventricular remodeling, cardiac function, inflammatory response and serum lipids in patients with acute myocardial infarction after coronary intervention
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):90-96.
5368 times
1078 times
Yu-Zhen NING
Siriguleng1
Xiang-Jun BAI
Lian SHUANG
R
osuvastatin
Co
r
ona
r
y inte
r
vention
Vent
r
icula
r
r
emodeling
Ca
r
diac function
Se
r
um lipids
Details
Effects of Tongshen Funao pills combined with conventional western medicine on vertigo degree, blood viscosity and serum D-dimer level in patients with posterior circulation ischemic vertigo
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):97-103.
5444 times
1171 times
Jin-Cai LI
Qing-Jie LUO
Fang-Huan LU
Xue-Ling ZHAO
Juan-Mei LI
Tongshen Funao pills
Poste
r
io
r
ci
r
culation ischemic ve
r
tigo
Deg
r
ee of ve
r
tigo
Blood viscosity
D-dime
r
Details
The effects of Shensong Yangxin capsule combined with metoprolol tartrate on cardiac function, ventricular remodeling and safety in patients with heart failure complicated with ventricular arrhythmia
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):104-110.
5929 times
1255 times
Bao-Liang GUO
Zhan-Lu LI
Xiao-Na LI
Shensong Yangxin capsule
Metop
r
olol ta
r
t
r
ate
Hea
r
t failu
r
e
A
r
r
hythmia
Vent
r
icula
r
r
emodeling
Details
Effects of tamsulosin and alfuzosin on quality of life and sexual function in patients with benign prostatic hyperplasia
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):111-118.
8050 times
2197 times
Sai-Feng HU
An Ding HU
Ting-Zhao QIAN
Benign p
r
ostatic hype
r
plasia
Tamsulosin
Alfuzosin
Details
Preventive effects of preoperative oral probiotic complex before radical surgery for colorectal cancer on postoperative infectious complications
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):119-124.
5442 times
1233 times
Si-Jiao CHEN
Wen-Jun WU
Ya-Wen ZHENG
Colo
r
ectal cance
r
P
r
obiotics
Complications
Postope
r
ative infection
Details
Research and pharmaceutical services by clinical pharmacists on antibiotic-related drug interaction in ICU
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):125-1131.
5248 times
1051 times
Hai-Tao WANG
Kang-Huai ZHANG
Jiao XIE
Na WANG
Qian-Ting YANG
Yan CAI
You-Jia LI
Li ZHANG
Yan WANG
Antimic
r
obial agents
Potential d
r
ug-antimic
r
obial agent inte
r
actions
Intensive ca
r
e unit
Pha
r
maceutical inte
r
vention
Details
Case analysis of fluconazole aggravating blood toxicity of pralsetinib
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):132-135.
5054 times
1036 times
Hao-Chun TANG
Jun MENG
Zheng-Zheng XIA
Shang-Jun HUA
Fluconazole
P
r
alsetinib
Cytoch
r
ome P450 3A4 inhibito
r
s
Th
r
ombocytopenia
Neut
r
openia
Details
A case of acute renal injury caused by improper administration of valaciclovir tablets
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):136-139.
6817 times
1606 times
Meng-Meng WANG
Fei HAO
Yan-Ni ZHANG
Valaciclovi
r
Acute kidney inju
r
y
I
r
r
ational d
r
ug use
Adve
r
se d
r
ug
r
eaction
Details
A case analysis of pancreatitis caused by dulaglutide
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):140-144.
6748 times
1247 times
Di HUAN
Jing MA
Zi-Jing WU
Jia-Hui LI
Rui WANG
Wen-Xiang LI
Dulaglutide
Panc
r
eatitis
Adve
r
se d
r
ug
r
eactions
Glucagon like peptide-1
r
ecepto
r
agonist
Details
Investigation on viable spore count of stainless steel carrier biological indicator for hydrogen peroxide vapor sterilization processes
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):145-149.
5771 times
1130 times
Wei-Jing PAN
Gao-Min LI
Ming-Ren WANG
Mei LIN
Jian LE
Hyd
r
ogen pe
r
ioxide vapou
r
ste
r
ilization p
r
ocesses
Biological indicato
r
Viable spo
r
e count
Details
上一页
1
2
32
33
34
35
36
37
38
129
130
下一页